Title : Ponatinib is a pan-BCR-ABL kinase inhibitor: MD simulations and SIE study.

Pub. Date : 2013

PMID : 24236021






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The inhibitors such as imatinib, dasatinib and nilotinib are effective drugs but are resistant to some BCR-ABL mutations. nilotinib ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens